[1] 王猛,周晓莹,王立新.超声造影在非霍奇金淋巴瘤中的应用进展[J].临床与病理杂志,2018,38(9):2030-2033. [2] SCHMITZ R,WRIGHT G W,HUANG D W,et al.Genetics and pathogenesis of diffuse large B-cell lymphoma [J].New Engl J Med,2018,378(15):1396-1407. [3] 刘靖,刘芳,刘连,等.经典Wnt信号通路与弥漫大B细胞淋巴瘤[J].佛山科学技术学院学报:自然科学版,2015,33(4):1-4. [4] MIZUNO S,HANAMURAI,OTAA,et al.Establishment and characterization of a novel vincristine‐resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region [J].FEBS Open Biol,2018,8(12):1977-1991. [5] GUTSCH J,WERTHMANN P G,ROSENWALD A,et al.Complete remission and long-term survival of a patient with a diffuse large B-cell lymphoma under viscum album extracts after resistance to R-CHOP: a case report [J].Anticancer Res,2018,38(9):5363-5369. [6] YANG L,JIAN G E,XIA R.Resistance to daunorubicin in acute myeloid leukemia is associated with mutations in the TET2 gene [J].Acta Univer Med Anhui,2018,53(2):246-250. [7] LIU YH,LEI PC,QIAO H,et al.MiR-9 Enhances the chemosensitivity of AML cells to daunorubicin by targeting the EIF5A2/MCL-1 axis[J].Int J Biol Scil,2019,15(3):579-586. [8] WANG M,CAI W R,MENG R,et al.miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin [J].Biochem Biophys Res Commun,2018,501(1): 48-54. [9] CHAWLA D,KAR R,GUPTA B,et al.Role of survivin and p53 expression in response of primary culture of ovarian cancer cells to treatment with chemotherapeutic agents [J].Int J Gynecol Cancer,2018,28(6):1239-1246. [10] 侯燕,胡群,熊昊,等.Survivin及其异变体、P53和MDM2在柔红霉素诱导Jurkat细胞凋亡中的变化[J].临床血液学杂志,2013,26(4):482-484,487. [11] JU R J,CHENG L,QIU X,et al.Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels [J].J Drug Target,2018,26(9):793-805. [12] 陈燕燕,付丽香,周欢,等.EGCG衍生物Y6联合柔红霉素对人肝癌裸鼠移植瘤生长及血管生成的影响[J].广西医科大学学报,2018,35(5):597-602. [13] HASHEMZAEI M,KARAMI S P,DELARAMIFAR A,et al.Anticancer effects of co-administration of daunorubicin and resveratrol in MOLT-4,U266 B1 and RAJI cell lines[J].Farmacia,2016,64(1):36-42. [14] 李莉,贾慧,李保平,等.上皮性卵巢癌中Let-7a及其靶基因HMGA2、Cyclin D1的表达[J].郑州大学学报:医学版,2017,52(4):398-402. [15] WEI M,SHI G,LIU J,et al.Effect of small interfering RNA targeting survivin gene on the expression of survivin and biological function of a human cutaneous squamous cell carcinoma cell line A431[J].Chin J Dermatol,2018,51(4): 305-309. [16] 杨惠雲,秦国慧,杨黎,等.食管鳞状细胞癌患者外周血和肿瘤组织来源的髓源抑制性细胞中PD-1和TIM-3的表达[J].郑州大学学报:医学版,2019,54(3):336-340. [17] 徐芝立,张丽红,张翼,等.RNA干扰肾癌Survivin基因表达降低786-O细胞增殖能力[J].河北医科大学学报,2017,38(11):1283-1286,1291. [18] 刘馨莲,綦黄鹏,魏仙.凋亡抑制因子Survivin的研究进展[J].中外医学研究,2017,15(20):161-163. [19] 王潇.miR-205通过靶向调控caspase-3表达调节神经胶质瘤的生物学行为[J].河北医科大学学报,2017,38(9):1024-1028,1032. [20] 张文婷,江莲,朱秀丽,等.地高辛对人B细胞淋巴瘤细胞增殖、凋亡的影响及其分子机制的研究[J].转化医学杂志,2018,7(2):74-78. [21] KANEKO N,KITA A,YAMANAKA K,et al.Combination of YM155,a survivin suppressant with A STAT3 inhibitor: A new strategy to treat diffuse large B-cell lymphoma[J].Leuk Res,2013,37(9):1156-1161. |